Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Tan

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trialsIrene L Wapnir, Stewart J Anderson, Eleftherios P Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancerAdam Brufsky, W Graydon Harker, J Thaddeus Beck, et al.
Breast Cancer Research and Treatment|November 18, 2006
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancerHope Rugo, Emma Shtivelman, Alejandra Perez, et al.
Journal of the National Cancer Institute|June 6, 2002
Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experienceSoonmyung Paik, John Bryant, Elizabeth Tan-Chiu, et al.
Journal of the Neurological Sciences|September 11, 2020
Characterisation of recent trends in cardiovascular risk factors in young and middle-aged patients with ischaemic stroke and/or transient ischaemic attackAditya Bhat, Gary C H Gan, David Makarious, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2011
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHERAdam M Brufsky, Musa Mayer, Hope S Rugo, et al.
Journal of Ultrasound|March 8, 2024
Morphometry of the sural nerve in diabetic neuropathy: a systematic reviewZhang Ludi, Matthias Yi Quan Liau, Bryan Song Jun Yong, et al.
Cancers|August 12, 2023
Trends in Head and Neck Cancer Mortality from 1999 to 2019 in Japan: An Observational AnalysisTsukasa Higashionna, Keisaku Harada, Akinari Maruo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31Elizabeth Tan-Chiu, Greg Yothers, Edward Romond, et al.
British Journal of Cancer|December 21, 2018
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind studyMark D Pegram, Igor Bondarenko, Marina Moreira Costa Zorzetto, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trialsIrene L Wapnir, Stewart J Anderson, Eleftherios P Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancerAdam Brufsky, W Graydon Harker, J Thaddeus Beck, et al.
Breast Cancer Research and Treatment|November 18, 2006
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancerHope Rugo, Emma Shtivelman, Alejandra Perez, et al.
Journal of the National Cancer Institute|June 6, 2002
Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experienceSoonmyung Paik, John Bryant, Elizabeth Tan-Chiu, et al.
Journal of the Neurological Sciences|September 11, 2020
Characterisation of recent trends in cardiovascular risk factors in young and middle-aged patients with ischaemic stroke and/or transient ischaemic attackAditya Bhat, Gary C H Gan, David Makarious, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2011
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHERAdam M Brufsky, Musa Mayer, Hope S Rugo, et al.
Journal of Ultrasound|March 8, 2024
Morphometry of the sural nerve in diabetic neuropathy: a systematic reviewZhang Ludi, Matthias Yi Quan Liau, Bryan Song Jun Yong, et al.
Cancers|August 12, 2023
Trends in Head and Neck Cancer Mortality from 1999 to 2019 in Japan: An Observational AnalysisTsukasa Higashionna, Keisaku Harada, Akinari Maruo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31Elizabeth Tan-Chiu, Greg Yothers, Edward Romond, et al.
British Journal of Cancer|December 21, 2018
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind studyMark D Pegram, Igor Bondarenko, Marina Moreira Costa Zorzetto, et al.
Pageof 4